| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.0052 | 0.9 |